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Conventional absolute contraindications to catheter-directed thrombolysis include active or recent hemorrhage and the presence
of localvascularinfection, both of which increasethe risk ofprocedure-related complicationssuch asbleeding andsystemic sepsis.
For this reason, lytic therapy of arterial thromboembolism under these circumstances is generally precluded. Herein, we describe
a unique case of safe catheter-directed lysis of an acutely thrombosed iliac artery following covered stent placement for treatment
of an actively bleeding infected pseudoaneurysm. Our management approach is discussed.
1.Introduction
Catheter-directed thrombolytic agent infusion represents an
eﬀectiveand well-established method ofrestoring bloodﬂow
in acute and subacute thromboembolic arterial occlusion
[1]. This therapy is associated with a 61.9–85.7% eﬃcacy
rate and a low major hemorrhagic complication rate of
approximately 5.1% [1–3]. Traditional contraindications to
catheter-based lytic therapy include active or recent hem-
orrhage, which increases risk for procedure-related bleeding
complications, and infection at the site of thrombosis, which
may result in systemic sepsis [4–6]. To date, there is limited
data on the safety of catheter-based thrombolysis in the
presence of these conditions. Herein, we describe a unique
case of safe catheter-directed thrombolysis of an acutely
thrombosed iliac artery pursued immediately after covered
stent insertion was performed for treatment of an actively
bleeding infected pseuodoaneurysm. A discussion of our
management approach and a review of the relevant literature
are presented.
2.CaseReport
Institutional review board approval is not required for single
retrospective case studies at our hospital. A 46-year-old
woman was referred to interventional radiology (IR) for
image-guided drainage of a large pelvic abscess discovered
after she presented to the emergency department (ED) with
fever and leukocytosis. The patient had a history of stage
IV rectal cancer (cloacogenic type) for which she under-
went palliative laparoscopic diverting sigmoid colostomy 26
months prior. In separate procedures, she also underwent
subsequentpelvicexenteration, abdominoperinealresection,
en bloc vaginectomy, bilateral salpingo-oophorectomy, right
groin lymphadenectomy, and perineal reconstruction with a
rectus abdominis myocutaneous ﬂap, as well as receiving a
high external beam radiation dose to the pelvis (45Gy) and
systemic chemotherapy with 5-ﬂuorouracil and oxaliplatin.
Computed tomography (CT) scan obtained in the ED
demonstrated a large heterogeneous air and ﬂuid ﬁlled
collection with thick irregular enhancing walls in the region
of the patient’s original primary tumor, suggestive of ﬁstula
formationtoadjacentbowelwithresultantabscessformation
within a large residual necrotic pelvic tumor (Figure 1). The
pelvic mass also encased the right iliac vessels, with the right
external iliac artery completely encompassed by infection.
SubsequentpercutaneousCT-guidedcatheterdrainageofthe
right pelvic abscess aspirated foul-smelling debris (Figure 2).
At the time of drainage, extra-anatomic arterial bypass with2 International Journal of Vascular Medicine
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Figure 1: Contrast-enhanced pelvic CT (a) reveals 12 × 7cm air- and ﬂuid-ﬁlled abscess (arrowheads) in abdominal right lower quadrant.
Encasement of right external iliac artery (arrow) by abscess noted. (b) Presence of bowel contrast (arrow) within collection conﬁrms ﬁstula
to colon.
Figure 2: Noncontrast CT image following percutaneous drainage
shows 12 French catheter (arrowheads) in anterior aspect of pelvic
abscess.
concurrent iliac artery embolization was recommended to
t h ep r i m a r ys u r g i c a ls e r v i c eg i v e nt h ee n v e l o p m e n to ft h e
iliac arteries within infected debris and the associated risk of
infected pseudoaneurysm formation of the involved vessels.
The patient clinically improved and was subsequently dis-
charged from thehospital severaldays laterwith thedrainage
catheter left in place.
Approximately three weeks later, the patient returned to
the ED with active bright-red bleeding from the right lower
quadrant drain as well as from her ostomy (950mL of blood
was present in the patient’s drainage bag). She was tachy-
cardic and hypotensive, with a heart rate ranging from
140 to 150 beats per minute and a systolic blood pressure
measuring approximately50–60mmHgpriortovasopressor
administration. Marked skin palor was evident. Laboratory
assessment revealed a hemoglobin level of 8.1g/dL. The
patientwasresuscitatedwithintravenousﬂuidhydrationand
transfusion of four units of packed red blood cells.
Immediate concern was for rupture of an infected right
iliac artery pseudoaneurysm, and, therefore, the patient was
urgentlytransferred totheIRangiographysuiteforemergent
preoperativeangiographyandpossibleendovasculartherapy.
Through a left common femoral artery 5 French 10cm long
sheath (Pinnacle; Terumo Medical Corp., Somerset NJ) a 5
French Omni Flush catheter (AngioDynamics, Queensbury
NY) was utilized for bilateral pelvic arteriography followed
by selective right common iliac arteriography using a 5
Frenchangledhydrophiliccatheter(Glidecath;TerumoMed-
ical Corp., Somerset NJ). Arteriography demonstrated active
hemorrhage from a pseudoaneurysm arising from the right
external iliac artery segment traversing the known pelvic
abscess (Figure 3).The Glidecath (Terumo)was immediately
exchanged for a 7mm balloon catheter (Ultra-Thin Dia-
mond; Boston Scientiﬁc,NatickMA) that was advanced over
a 0.035inch stiﬀ guide wire, positioned across the pseudoa-
neurysm and inﬂated in an attempt to tamponade further
bleeding.
After discussing the angiographic ﬁndings and potential
treatment options with the colorectal and vascular surgery
services, a request was made to place covered stents along
the right external iliac artery to exclude the bleeding pseu-
doaneurysm. The patient was deemed to be an unsuitable
candidate for emergent operative intervention given poor
clinical status and low likelihood for postoperative survival
following an open procedure. Furthermore, an operative
approach from theright groin was thoughtto beunfavorable
due to local cancer spread, radiation-related tissue ﬁbrosis,
and suspected healing impingement due to poor tissue qual-
ity, lymphadenectomy, and presence of tissue ﬂaps.
The 5 French left groin sheath was then exchanged for
a 9 French 55cm long sheath (Raabe Flexor Check-Flo;
Cook Medical, Bloomington IN), which was guided into the
distal right external iliac artery. Three overlapping 9mm ×
60mm, 8mm × 80mm, and 8mm × 60mm Fluency-Plus
(Bard, Murray Hill NJ) covered stents were then deployed
across the right external iliac artery (Figure 4)t ot h el e v e lo f
the right femoral artery, successfully excluding the bleeding
pseudoaneurysm. Three stents were used in order to cover
the entire length of vessel traversing the right pelvic abscess.International Journal of Vascular Medicine 3
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Figure 3: Digital subtraction (a) and unsubtracted (b) images from right iliac arteriogram reveal contrast extravasation (arrowheads) from
right external iliac artery pseudoaneurysm (arrow).
Figure 4: Fluoroscopic spot image demonstrates covered stents
deployed across right commonand external iliac arteries.
Noheparinwas administered atthetimeofstentdeployment
due to active bleeding. Due to potential risk of infectious
complications, the patient was treated with intravenous
piperacillin-tazobactam (Zo s y n ;W y e t h ,M a d i s o nN J )a n d
metronidazole (Flagyl; Pﬁzer, New York NY), which were
continued for the duration of her ten-day hospital stay.
Immediate postdeployment arteriography revealed thro-
mbosis of the newly stented right external iliac artery with
thrombus extending to the right common femoral artery bi-
furcation (Figure 5), likely related in part to prolonged bal-
loon tamponade. The initially asymptomatic right low-
er extremity gradually began to demonstrate signs and sym-
ptoms of signiﬁcant limb ischemia prompting repeat
discussion of surgical intervention. At this point, treatment
options were discussed further with the surgical service fol-
lowed by the patient’s family. Interventional considera-
tions included catheter-directed thrombolysis, mechanical
thrombectomy, stent-in-stent placement, surgical embolec-
tomy, arterial bypass, and limb amputation. A decision
was made to revascularize the right lower extremity using
catheter-directedlow-dosealteplasethrombolysis,asthiswas
believed to oﬀer the best chance for vessel recanalization
andlimbsalvagewhileminimizing potentialmorbiditybased
on our excellent institutional experience using low-dose
alteplase infusion. Mechanical thrombectomy, while possi-
ble, was felt to carry risk of clot disruption, distal arterial
embolic disease, and secondary tissue ischemia. Stent-in-
stent placement was not believed to permit suﬃcient return
of luminal caliber in the setting of large thrombus volume
and was felt to be associated with risk of distal embolization.
Surgical embolectomy and arterial bypass were not pursued
due to the hostility of the tumor-laden and postradiation
surgical ﬁeld. Limb amputation, while possible, was felt to
represent a salvage therapy if limb-sparing maneuvers were
unsuccessful.
For thrombolysis, a 5 French Glidecath (Terumo) was
advanced into the proximal right external iliac artery, and
a coaxial 0.035inch SOS infusion guide wire (Medtronic,
Minneapolis MN) was positioned within the thrombosed
right common femoral artery. Alteplase (Activase; Genen-
tech, South San Francisco CA) was delivered via the catheter
and coaxial wire with a total infusion dose of 0.48mg per
hour (Figure 5), with systemic heparin titrated to maintain a
partial thromboplastin time (PTT) of approximately 60–80
seconds. As per institutional routine, complete blood count,
coagulation proﬁle, and ﬁbrinogen levels were monitored
every six hours during lysis.4 International Journal of Vascular Medicine
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Figure 5: Right common femoral arteriogram (a) reveals acute thrombosis (arrow) of distal segment of stented artery. Of note, unsaved
manual injections of contrast better documented thrombus burden throughout entire course of stented iliac artery segment. Fluoroscopic
spot image (b) shows 5 French catheter (arrow) and infusion wire (arrowheads) system used for catheter-directed thrombolysis.
Following eight hours of thrombolytic therapy, a repeat
angiogram of the right lower extremity demonstrated near
complete lysis of the extensive thrombus. A small amount
of residual emboli remained, occluding a branch of the pro-
fundafemorisartery andthelateralplantarartery ofthefoot.
Both catheters were exchanged with the catheter tips reposi-
tioned to optimize delivery of thrombolytic agent to residual
clot. After an additional 12 hours of therapy, angiographic
reassessment demonstrated complete lysis of thrombus
(Figure 6). The patient remained hemodynamically stable
throughout the procedure.
The patient subsequently clinically improved, with a dis-
charge from the hospital after ten dayswithout any recurrent
bleedingepisodesorinfectious complicationofcoveredstent
insertion. Her right lower quadrant abscess drain was un-
eventfullyremovedincolorectalsurgeryclinicapproximately
two months after initial placement. Follow-up CT scan per-
formed four months after covered stent insertion revealed
local progression of right lower quadrant tumor, buttressing
the patent stented right external iliac artery (Figure 7). The
patientsuﬀerednoadditionalbleedingepisodesorinfectious
events, as evidenced by lack of clinical signs and symptoms
as well as hematologic laboratory changes, and subsequently
expired dueto advanced metastatic cancer involving her liver
while in hospice care eight months after-procedure.
3.Discussion
The presence of vascular infection signiﬁcantly complicates
conventional surgical and endovascular therapies of pseu-
doaneurysms.Treatmentofinfectedpseudoaneurysmstradi-
tionally involves operative ligation and resection. In a meta-
analysis of the literature, M. K. Razavi and M. D. Razavi
Figure 6: Digital subtraction angiogram, obtained 28 hours after
initiation of catheter-directed thrombolysis, shows patency of
stented right commonand external iliac arteries.
report an early mortality rate as high as 43% following
surgical repair of infected aneurysms depending on patient
condition [7], and successful repairs are still associated with
amputation rates greater than 20% [8]. With endovascular
therapy, infected pseudoaneurysm treatment with covered
stent exclusion shows an early mortality rate of 5.6%,
and the incidence of late pseudoaneurysm-related mortality
and complications are 12.2% and 7.8%, respectively [7].
Similarly, in a meta-analysis of endovascular stent repair for
infected aortic aneurysms, Kan et al. reported an overallInternational Journal of Vascular Medicine 5
Figure 7: Contrast-enhanced CT scan, obtained four months
after-stent insertion, demonstrates interval local tumor progres-
sion (arrowheads) but maintained patency of stented iliac artery
(arrow).
mortality of 20.8%, with persistent infection in 22.9% of
cases [9]. 12-month survival in patients with persistent
infection was 39% compared to 94% in the infection-free
group [9]. Predictors of adverse outcome in endovascular
stent repair of infected aortic aneurysms include aneurysm
r u p t u r ea n dt h ep r e s e n c eo fa c t i v ei n f e c t i o na tt h et i m eo f
stent deployment [9].
Ordinarily, the use of a covered stent is contraindicated
in an area of infection due to potential bacterial colonization
of the graft material [9, 10], and covered stent insertion
is generally not felt to provide a long-term solution for
treatment of infected pseudoaneurysms [8]. While possible
alternatives, such as coil embolization with extra-anatomic
vascular surgical bypass, were consideredin our case, surgery
was precluded by poor patient clinical status and expected
low likelihood of post-operative survival. The decision to
proceedwithendovascularpseudoaneurysmexclusionwitha
covered stent in an infected ﬁeld was made after considering
these factors. Subsequent conventional angiography enabled
prompt diagnosis and management, and the patient was
treated with an aggressive antibiotic regimen to prevent
infection of the newly placed covered stents. Notably, there
was no postprocedure laboratory evidence of bacteremia to
suggest colonization of the covered stent.
An additional element of complexity was added to our
case when thrombosis developed within the covered stent
minutes after deployment, limiting blood ﬂow in the right
lower extremity and threatening critical limb ischemia. In
general,knownactiveorrecenthemorrhage constitutemajor
absolute contraindications for thrombolysis therapy [4, 5].
Additional absolute contraindications include established
cerebrovascular events, active bleeding diathesis, recent gas-
trointestinal bleeding, intracranial or spinal surgery within
the last three months, and intracranial trauma [4, 5]. Recent
cardiopulmonary resuscitation, recent major nonvascular
surgery or trauma, uncontrolled hypertension (systolic
blood pressure ≥180mmHg or diastolic blood pressure
≥110mmHg), intracranial tumor, and puncture of non-
compressible vessel constitute relative major contraindica-
tions,alsoincreasinghemorrhagerisk[4,5].Accordingly,use
of thrombolysis in our case could have been contraindicated
on two grounds: recent bleeding as well as the presence of
active infection with possible septic thrombosis.
On review of the English language literature, the safety of
systemic or catheter-directed thrombolysis in the setting of
active hemorrhage or other absolute procedure contraindi-
cations has not been extensively studied. While sporadic case
reports describe the safe use of intravenous [11]o rc a t h e t e r -
based [12] thrombolysis in postsurgical patients, for exam-
ple, large sample size prospective or retrospective investiga-
tions assessing the safety thrombolysis in actively bleeding
patients have not been performed, likely due to unethical
and unnecessary risk to study subjects. While recent major
hemorrhage from a bleeding mycotic pseudoaneurysm con-
stituted an absolute contraindication to thrombolysis in our
case, we felt that lytic therapy could be pursued safely given
the secure treatment of the bleeding source with stent exclu-
sion prior to administration of thrombolytic medications.
Although catheter-directed thrombolysis was not the only
treatment option, with mechanical thrombectomy, stent-
in-stent placement, surgical embolectomy, arterial bypass,
and limb amputation as alternatives, it was felt to represent
the treatment option with highest likelihood for success
and lowest morbidity and mortality rates in our complex
and medically unstable patient. Should the patient have
developed any signs or symptoms suggesting hemorrhage
during the course of therapy, thrombolysis would have been
immediately terminated.
4.Conclusion
In summary, this case demonstrates successful use of cathe-
ter-directed thrombolysis in the setting of recent hemorrhage
and an infected ﬁeld, and therein exempliﬁes unique appli-
cation of a traditional catheter- b a s e dt e c h n i q u ei na nu n c o n -
ventional situation. While the use of thrombolysis cannot be
advocated in patients with active or recent bleeding events
and existing infection on the basis of this single case, the
safety of lysis in a nontraditional application is highlighted
herein and serves as a reminder to endovascular specialists
that measures thought to be contraindicated may rarely be
safely performed and can provide beneﬁt to patients, in our
case contributing to eight months of prolonged lifespan. As
a precaution, however, it warrants mention that the decision
to proceed with such an intervention need to be made on a
case-by-case basis, with the best interest of the patient taken
into account and after thorough discussion of the procedure
beneﬁts, risks, and alternatives with the patient, family, and
consulting physicians.
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